|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: EPICOR SOFTWARE CORP, 10-Q, EX-10.72, 2000-11-14 |
Next: CELL THERAPEUTICS INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE NINE MONTHS
ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 19,350
<SECURITIES> 40
<RECEIVABLES> 86,691
<ALLOWANCES> 25,107
<INVENTORY> 0
<CURRENT-ASSETS> 89,027
<PP&E> 59,531
<DEPRECIATION> 46,256
<TOTAL-ASSETS> 132,420
<CURRENT-LIABILITIES> 93,033
<BONDS> 253
0
7,501
<COMMON> 42
<OTHER-SE> 31,591
<TOTAL-LIABILITY-AND-EQUITY> 132,420
<SALES> 57,361
<TOTAL-REVENUES> 166,023
<CGS> 0
<TOTAL-COSTS> 82,349
<OTHER-EXPENSES> 119,872
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (35,374)
<INCOME-TAX> 0
<INCOME-CONTINUING> (35,374)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (35,375)
<EPS-BASIC> (0.85)
<EPS-DILUTED> (0.85)
</TABLE>
|
|